Major drug-drug interaction between sirolimus and apalutamide in a liver transplant recipient

被引：0
作者：
Dumortier, Jerome [1 ,2 ]
Colombel, Marc [2 ,3 ]
Maillet, Denis [4 ,5 ]
机构：
[1] Hosp Civils Lyon, Hop Edouard Herriot, Federat Special Digest, Lyon, France
[2] Univ Claude Bernard Lyon 1, Lyon, France
[3] Hosp Civils Lyon, Hop Edouard Herriot, Serv Urol, Lyon, France
[4] Inst Cancerol Hosp Civils Lyon IC HCL, Ctr Hosp Lyon Sud, Serv Oncol Med, Oullins Pierre Benite, France
[5] Fac Med Jacques Lisfranc, St Etienne, France
来源：
TRANSPLANT IMMUNOLOGY | 2024年 / 86卷
关键词：
Drug-drug interaction; Sirolimus; Liver transplant; POLYMORPHISMS;
D O I：
10.1016/j.trim.2024.102103
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 6 条
  • [1] Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy
    Anglicheau, D
    Le Corre, D
    Lechaton, S
    Laurent-Puig, P
    Kreis, H
    Beaune, P
    Legendre, C
    Thervet, E
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (03) : 595 - 603
  • [2] Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
    Chi, Kim N.
    Chowdhury, Simon
    Bjartell, Anders
    Byung Ha Chung
    Gomes, Andrea J. Pereira de Santana
    Given, Robert
    Juarez, Alvaro
    Merseburger, Axel S.
    Ozguroglu, Mustafa
    Uemura, Hirotsugu
    Ye, Dingwei
    Brookman-May, Sabine
    Mundle, Suneel D.
    McCarthy, Sharon A.
    Larsen, Julie S.
    Sun, Weili
    Bevans, Katherine B.
    Zhang, Ke
    Bandyopadhyay, Nibedita
    Agarwal, Neeraj
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (20) : 2294 - +
  • [3] Pharmacokinetic Drug-Drug Interaction of Apalutamide, Part 1: Clinical Studies in Healthy Men and Patients with Castration-Resistant Prostate Cancer
    Duran, Ignacio
    Carles, Joan
    Bulat, Iurie
    Hellemans, Peter
    Mitselos, Anna
    Ward, Peter
    Jiao, James
    Armas, Danielle
    Chien, Caly
    [J]. CLINICAL PHARMACOKINETICS, 2020, 59 (09) : 1135 - 1148
  • [4] Clinical relevance of sirolimus drug interactions in transplant patients
    Sádaba, B
    Campanero, MA
    Quetglas, EG
    Azanza, JR
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (10) : 3226 - 3228
  • [5] uptodate, Cytochrome P450 3A (Including 3A4) Inhibitors and Inducers
  • [6] Wang J, 2009, EXPERT REV MOL DIAGN, V9, P383, DOI [10.1586/erm.09.11, 10.1586/ERM.09.11]
1